Financials
- Market Capitalization 25.75 M
- Employee 14
- Founded 2008
- CEO Steven C. Quay
- Website www.atossatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002NCD8C8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4480 | NNVC NanoViricides, Inc. Common Stock | 1.24 USD | -3.88% | -5.34% | -20.00% | +22.76% | 26.84 M USD | ||
| 4484 | LTRN Lantern Pharma Inc. - Common Stock | 2.07 USD | -4.17% | -8.81% | -17.53% | -50.60% | 26.46 M USD | ||
| 4501 | EVAX Evaxion A/S - American Depositary Share | 3.01 USD | -4.44% | -9.34% | +7.50% | -9.34% | 25.10 M USD | ||
| 4512 | TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.82 USD | +0.55% | -2.67% | -14.15% | -49.44% | 24.28 M USD |